Amylyx Pharmaceuticals, Inc. (AMLX) › Net IncomeAmylyx Pharmaceuticals, Inc. (AMLX) — Net IncomeAnnual figures by period end, from SEC filings.2021-12-31: -$87.93M2022-12-31: -$198.38M2023-12-31: $49.27M2024-12-31: -$301.74M2025-12-31: -$144.74M-$144.74M2021-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$144.74M—2026-03-03From 2025-01-012024-12-31-$301.74M-712.4%2026-03-03From 2024-01-012023-12-31$49.27M—2025-03-04From 2023-01-012022-12-31-$198.38M—2024-02-22From 2022-01-012021-12-31-$87.93M—2024-02-22From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)